Sabra Health Care REIT, Inc. (SBRA)

Sabra Health Care REIT Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	65.44	155.61	126.71	13.76	-77.61	-113.26
Depreciation & Amortization	204.55	182.12	164.76	177.27	181.16	192.5
Gain (Loss) on Sale of Assets	-24.22	3.52	-2.1	76.63	12.01	-12.3
Gain (Loss) on Sale of Investments	-	-	-	-	57.78	164.13
Asset Writedown	3.66	7.32	18.47	14.33	94.04	9.5
Stock-Based Compensation	13.13	11.36	8.99	7.92	7.45	7.91
Income (Loss) on Equity Investments	1	3.89	5.84	6.37	40.25	27.96
Change in Accounts Receivable	-16.5	-11.45	-15.46	-11.08	-6.44	8.22
Change in Accounts Payable	7.81	1.6	-7.09	8.34	-13.25	14.48
Other Operating Activities	15.13	-4.3	10.99	6.85	20.19	53.31
Operating Cash Flow	371.57	348.61	310.54	300.57	315.73	356.39
Operating Cash Flow Growth	9.66%	12.26%	3.32%	-4.80%	-11.41%	0.43%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Acquisition of Real Estate Assets	-737.44	-494.45	-191.14	-163.39	-146.68	-142.1
Sale of Real Estate Assets	178.67	88.64	96	247.62	95.3	100.72
Net Sale / Acq. of Real Estate Assets	-558.77	-405.82	-95.14	84.24	-51.37	-41.38
Investment in Marketable & Equity Securities	9.6	8.05	1.85	-10.25	-145.56	-7.77
Other Investing Activities	0.29	6.05	2.38	5.8	-0.78	-
Investing Cash Flow	-334.97	-377.96	-109	103.13	-216.25	-336.2

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	-	609.81	14.6	12.19	204.05	791.52
Long-Term Debt Repaid	-	-502.09	-2.03	-106.32	-81.27	-767.66
Net Debt Issued (Repaid)	153.34	107.72	12.56	-94.13	122.78	23.86
Issuance of Common Stock	251.28	227.78	86.12	-	-	308.71
Common Dividends Paid	-298.06	-289.5	-280.15	-277.45	-277.16	-262.92
Total Dividends Paid	-298.06	-289.5	-280.15	-277.45	-277.16	-262.92
Other Financing Activities	-6.55	-5.24	-0.09	-38.72	-7.33	-39.51

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	0.08	0.39	-0.36	-0.61	0.27	0.03
Net Cash Flow	136.69	11.8	19.62	-7.21	-61.95	50.36

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Levered Free Cash Flow	155.12	309.78	244.17	254.32	78.48	344.75
Unlevered Free Cash Flow	227.64	380.09	315.91	324.93	144.4	406.39

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	114.99	110.96	105.2	102.41	97.72	85.46
Cash Income Tax Paid	1.5	1.5	1.39	1.67	1.66	1.84
Change in Working Capital	-8.7	-9.85	-22.55	-2.73	-19.69	22.7

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 15, 2026

Data Sources Report a data error